SeraCare Life Sciencescompany agreed to be sold to an affiliate of Linden Capital Partners, announced on Feb 13, 2012.
8-KLazard Freres & Co.firm advised the seller.
8-KWilliam Blair & Companyfirm advised the buyer.
8-KThe filing puts the value at $82M.
8-KLinden Capital Partnersfirm lists SeraCare Life Sciencescompany as a current portfolio company.
WebsiteLinden Capital Partnersfirm also worked on ArtesRxcompany, on Aug 24, 2026.
Websitelisting
At a glance
Who was on each side
Seller's adviserLazard Freres & Co.
Buyeran affiliate of Linden Capital Partners
InvestorLinden Capital Partners
Buyer's adviserWilliam Blair & Company
Parties
first 2 of 4
| Party | Role | Source |
|---|---|---|
| an affiliate of Linden Capital Partners | Buyer | 8-K |
| Linden Capital Partners | Investor | 8-K |
Value
| Kind | Amount | Basis | Source |
|---|---|---|---|
| Price | $82M | transaction value | 8-K |
More deals
first 2 of 12
| Date | Deal | Firms | Source |
|---|---|---|---|
| Oct 27, 2026 | Vexcel Group, Inc · Sale | William Blair & Company, Goldman Sachs & Co. | 8-K |
| Oct 5, 2026 | StormTrap Investments LLC · Sale | Raymond James & Associates, William Blair & Company | 8-K |
10 more deals
Deals with Linden Capital Partners, Lazard Freres & Co. and William Blair & Company.
Sign up free to see the first 5, or become a member to see all 12.